GSK Quadrivalent Influenza Candidate Vaccine (GSK2321138A)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK Quadrivalent Influenza Candidate Vaccine (GSK2321138A), covering 2016-06-20 to 2016-06-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children [Phase 3]